Drugs / AL-39324
Trials 1 · a red edge is where a trial was stopped
| Phase | Registry id | Dates | Indication | Sponsor | Status | Outcome |
|---|---|---|---|---|---|---|
| Phase 2 | NCT00992563 | Jun 2010 → May 2011 | wet macular degeneration | Alcon Research | Completed | No outcome recorded |
Evidence & citations 2 cited values
Every value below carries the sentence it was read from. 1 source stands behind the page.
| Field | Value | Cited text |
|---|---|---|
| Known as | AL-39324 | ClinicalTrials.gov intervention name — accepted as the source's own label NCT00992563 ↗ |
| Route | Intravitreal | “AL-39324 ophthalmic suspension, single intravitreal injection” NCT00992563 ↗ |